1598 Mrv0541 02231215352D 22 23 0 0 1 0 999 V2000 5.9559 -0.2382 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0 2.6625 1.5588 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.4474 -1.2387 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 5.7079 -1.8618 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 4.3488 -2.3033 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3.8613 -0.6507 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 7.6059 1.1908 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 8.8434 1.9053 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 3.8613 0.1743 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 3.0295 0.1778 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 4.6459 0.4292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0295 -0.6541 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.4474 0.7623 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 4.6459 -0.9056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.1309 -0.2382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.6500 0.5504 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.9009 -1.6903 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6.3684 0.4763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 7.1934 0.4763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 8.4309 1.1908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.7595 0.8264 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 2.4195 -0.0742 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 1 15 1 0 0 0 0 1 18 1 0 0 0 0 13 2 1 1 0 0 0 3 12 2 0 0 0 0 4 17 1 0 0 0 0 5 17 2 0 0 0 0 6 9 1 0 0 0 0 6 12 1 0 0 0 0 6 14 1 0 0 0 0 7 19 1 0 0 0 0 7 20 2 0 0 0 0 8 20 1 0 0 0 0 9 10 1 0 0 0 0 9 11 1 0 0 0 0 9 21 1 6 0 0 0 10 12 1 0 0 0 0 10 13 1 0 0 0 0 10 22 1 1 0 0 0 11 15 1 0 0 0 0 13 16 1 0 0 0 0 14 15 2 0 0 0 0 14 17 1 0 0 0 0 18 19 1 0 0 0 0 M END > DB01598 > drugbank > [H][C@]12CC(SCC\N=C\N)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O > InChI=1S/C12H17N3O4S/c1-6(16)9-7-4-8(20-3-2-14-5-13)10(12(18)19)15(7)11(9)17/h5-7,9,16H,2-4H2,1H3,(H2,13,14)(H,18,19)/t6-,7-,9-/m1/s1 > ZSKVGTPCRGIANV-ZXFLCMHBSA-N > C12H17N3O4S > 299.346 > 299.093976737 > 6 > 37 > 0.0005644146216183752 > 31.096207372789912 > 1 > 3 > 0 > 0 > (5R,6S)-3-({2-[(E)-(aminomethylidene)amino]ethyl}sulfanyl)-6-[(1R)-1-hydroxyethyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid > -0.19 > -3.851167554456184 > -2.59 > 0 > 0 > 2 > 0 > 15.000723709271549 > 3.4412917848266447 > 10.87815287695515 > 116.21999999999998 > 75.84340000000002 > 6 > 1 > 7.76e-01 g/l > biotin > 0 > DB01598 > approved > Imipenem > (5R,6S)-3-((2-(Formimidoylamino)ethyl)thio)-6-((R)-1-hydroxyethyl)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid; (5R,6S)-3-(2-Formimidoylamino-ethylsulfanyl)-6-((R)-1-hydroxy-ethyl)-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid; (5R,6S)-6-((R)-1-Hydroxyethyl)-3-(2-(iminomethylamino)ethylthio)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carbonsaeure; Imipenem; Imipenem anhydrous; Imipenemum; N-formimidoyl thienamycin; N-formimidoylthienamycin > Imipenem; Imipenem and Cilastatin; Imipenem and Cilastatin for Injection; Imipenem and Cilastatin for Injection USP; Imipenem and Cilastatin for Injection, USP; Primaxin; Primaxin 250; Primaxin 500; Primaxin IV; Primaxin IV 250/250 Add-vantage Vial; Primaxin IV 500; Primaxin Im; Recarbrio; Taro-imipenem-cilastatin > Imipenem monohydrate $$$$